NOVPUB
Chapter 1308: Chapter 1163: Profit Sharing Agreement (Please Subscribe!)
𝓷ℴ𝓿𝓅𝓊𝒷.𝓬𝓸𝓂
The press conference ended just over ten minutes ago.
All flights to Myanmar for this month sold out immediately.
Even next month’s flights were gone, with many patients’ families calling the airline, requesting additional flights, and the airline did not hesitate, immediately scheduling flights according to the maximum capacity given by Myanmar.
You should know,
The flight takeoff and landing capacity of a country is limited.
The number, size, scale, and the supporting facilities of airports all restrict the total volume of flights, but thankfully, Myanmar had massively expanded and built new airports in recent years.
Greatly alleviating the pressure on air transportation.
However,
within less than a day, they were sold out again.
Thus,
those companies thought of the neighboring countries.
They could get through by land routes via neighboring countries. In other words, as long as it bordered Myanmar, it could serve as a transfer flight—what the patients did to get to Myanmar was their business.
...
In just these two days,
hotel rooms in Myanmar’s major cities were also booked up, many of them by family members accompanying the patients, as not everyone could stay in a hospital, especially in Xin’an City, where circles of resort hotels were fully booked.
There was no choice.
Currently, these medicines had not passed the scrutiny of other countries.
Only here were they available.
Even with some doubts about the efficacy,
if I, damn it, only had less than a month left to live, treating a dead horse as if it were alive, trying for a slim chance, it was better than simply dying. They didn’t want to miss a chance.
They just didn’t believe
that this company would dare to deceive the entire world.
...
August 1st.
The Transcription Fluid arrived at the headquarters of various large pharmaceutical companies.
Without hesitation,
they immediately organized the best scientific research teams for analysis, testing, and pharmacological experiments on mice and, seeing the results, they were frustrated. Indeed, there was no such good thing in the world.
They sold it to you.
Making sure you couldn’t replicate it.
They couldn’t even figure out the chemical composition, let alone prepare it. Testing the high-concentration solution on mice did indeed suppress the division of cancer cells.
Johnson & Johnson,
the largest pharmaceutical company in the world.
Apple Lab Center.
The CEO listened quietly to the senior biologist’s introduction about the "Transcription Fluid." The more he heard, the heavier his heart sank. Although anti-cancer drugs were not their company’s main income source.
Yet,
their company’s throne might not be secure.
Because this company was too extreme. The "Transcription Fluid" was just one of their products. Who knows how many other special-effect medicines they had, along with their unfathomable research and development capabilities.
After the report,
the company’s executives were summoned for a meeting.
"This company will be our biggest competitor."
"Can’t we do something internally?"
"No, it’s a solid front right now. This company is backed by the powers that be in that country. Now several departments here in the United States are in a huge mess, and the military has gotten involved. There’s no way they could take up our case."
Speaking of this,
the CEO’s mood was terrible. God knows why the major security departments, like mad dogs, keep biting more and more people. Now, even the military is involved.
He really couldn’t understand.
Just then,
his secretary walked in, handing him a document. After reading it, the CEO looked up.
"Just now, the Myanmar Health Group sent a document inviting us to be their agent for the ’Transcription Fluid.’ They can supply us with this fluid in large quantities, ensuring our lawful profits."
"What? They’re selling the fluid?"
"Yes."
"What are the conditions?"
"To help the ’Transcription Fluid’ quickly pass the U.S. medicine registration, and they’re only providing the fluid, not the preparation technology. We can sign a long-term supply contract to secure our interests," the CEO said.
"Are they afraid of us?"
"I don’t think so; they just don’t want a direct conflict. Otherwise, if we mess things up, their ’fluid’ might not get approved and could only be sold in their country."
"We need to demand the opening of preparation technology."
"Exactly."
"..."
As his subordinates argued,
The CEO tapped the table.
The room quieted down immediately.
"This is a bit difficult. At the end of the document, they also mentioned something else. They will invite governments from various countries to collectively promote the Health Loan Plan. If we don’t agree, they might go directly to governments for cooperation."
"If it goes that way, we’d be in a passive position." A vice president frowned.
Carrot and stick.
The CEO was helpless.
This move was damn tough. If you don’t cooperate with me, I’ll go straight to governments for cooperation, possibly even for comprehensive medicine agency cooperation. This would directly destroy their interest system.
Now,
The Myanmar Health Group had shown them a clear way forward: be my agent, how you make money in your country is your business, not mine. If you don’t agree, I’ll just flip the table.
You could say,
This was a ’profit-sharing agreement.’
An extremely domineering agreement.
"Bastards, thinking we’re easy to bully." A hot-tempered vice president slammed the table; it had always been them threatening others. He didn’t expect to be threatened today, like collecting a ’protection fee.’
At that moment,
in his mind,
he had thought of dozens of ways to cause trouble for the Myanmar Health Group.
Medical incidents.
Just a few occurrences,
Then widely broadcast it.
It wouldn’t be too hard to get the Myanmar Health Group into trouble. Public opinion was always manipulated. This kind of thing was not much harder than drinking water for them.
"Don’t break the table. We are here to make money, not to vent anger. This matter isn’t settled yet. Other companies could also have received this document. We need to make a decision quickly."
The CEO’s sanity hadn’t yet left him.
"We can’t monopolize this."
"If we cooperate, it’s not a bad option, but we need them to agree that other special-effect drugs must pass our approval before entering the Western markets, which would guarantee our interests to the greatest extent."
"That makes sense. Their generic medicine technology is so powerful; those special-effect drugs shouldn’t be bad."
"..."
The conversation shifted quickly.
Yet,
"Everything depends on the efficacy of the ’Transcription Fluid.’ We can start negotiations and engagement. If it truly proves effective, it’s not too late to introduce it."
"Yes."
"Let’s wait and see. Also, we need to speed up deciphering the components of the ’Transcription Fluid,’ be prepared on both fronts."
"..."
This situation
unfolded inside the executive meetings of global pharmaceutical giants.
Their decision was startlingly unanimous.
--- Wait and see.
It was this minor document
that made those prepared to target the Myanmar Health Group stand down. When interests were involved, why beat each other up? Without these people causing trouble, Tang Qing’s life might be a bit quieter.
